• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Jarvik Heart

Leviticus Cardio, Jarvik Heart unveil wireless LVAD

February 7, 2019 By Fink Densford

Jarvik Heart and Leviticus Cardio yesterday unveiled a new collaborative wirelessly-powered left ventricular assist device and touted its recent first-in-human use. An article on the new heart and its first implantation was recently published in the Journal for Heart and Lung Transplantation, the companies said. The device, dubbed the Fully Implanted Ventricular Assist Device (FIVAD), […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, Structural Heart Tagged With: Jarvik Heart, Leviticus Cardio

Bone adhesive dev Launchpad Medical raises $9m | Medtech Funding Roundup

January 10, 2019 By Fink Densford

Launchpad Medical has raised $8.5 million in a new round of equity financing, according to recently posted SEC filings. The Lowell, Mass.-based medtech company is developing the Tetranite injectable, synthetic adhesive solution intended for bone repair. Tetranite is bioresorbable and is designed to provide instant adhesive capabilities to treat fractured bone and to stabilize metal […]

Filed Under: Business/Financial News, Featured, Wall Street Beat Tagged With: ALung Technologies Inc., babyscripts, BioCardia, conextionsmedical, Conventus Orthopaedics, cynerio, decisionsciencesmedical, Jarvik Heart, launchpadmedical, Leviticus Cardio, Philips, seraphbiosciences

FDA approves Jarvik Heart trial for pediatric cardiac assist device

October 21, 2016 By Brad Perriello

Jarvik Heart said today that the FDA approved an investigational device exemption trial of its miniature left ventricular assist device in patients of less than 1 year of age to 10 years. The 88-patient study is designed to compare the Jarvik 15mm LVAD with Berlin Heart‘s Excor device as a bridge to transplant over 6 months. […]

Filed Under: Clinical Trials, Structural Heart Tagged With: Jarvik Heart

Jarvik Heart wins Japanese approval for LVAD

December 6, 2013 By Chris Walker

Jarvik Heart wins Japanese approval for LVAD

Jarvik Heart said it won pre-market approval from the Japanese Pharmaceuticals & Medical Devices Agency for its Jarvik 2000 heart, a left ventricular-assist device.

New York-based Jarvik Heart said the device is the smallest LVAD approved for long-term use in Japan.

Filed Under: News Well, Pre-Market Approval (PMA), Regulatory/Compliance, Structural Heart Tagged With: Japanese Pharmaceuticals and Medical Devices Agency, Jarvik Heart

Study: Stents no better than pills for some heart patients | MassDevice.com On Call

February 28, 2012 By MassDevice staff Leave a Comment

Updated: March 15, 2012 9:30 a.m.

MassDevice On Call

MASSDEVICE ON CALL — Stable heart disease patients were no better off with a stent with less-costly drug therapy in a recent study comparing the 2 treatments. *

Implanting a stent to prop open blocked arteries represents a more costly alternative that failed to improve outcomes in stable patients, according to researchers from the Stony Brook University Medical Center in New York.

Filed Under: Healthcare Reform, Legal News, News Well, Research & Development, Stents, Structural Heart Tagged With: Jarvik Heart, U.S. Congress

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy